Fox Business - The Power to Prosper
Search Site

Drug Companies

What the UnitedHealth-Catamaran deal means for consumers

Manhattan Institute Scholar Avik Roy on the impact of the UnitedHealth deal to buy Catamaran.

Read More

  1. Are physicians over prescribing testosterone?

    Urologist Dr. Paul Thompson on whether physicians over prescribing testosterone and FDA warnings.

  2. Benefits of digitizing health-care data

    Practice Fusion CEO Ryan Howard on the benefits of digitizing health-care records.

  3. Cyber attacks the greatest threat to national security?

    Former President George W. Bush, President Obama Cyber Security advisor Howard Schmidt on intelligence officials warning cyber attacks pose the greatest risk to U.S. national security.

  4. LA hospital: 179 potentially exposed to ‘Superbug’

    Fox News Medical A Team Dr. Marc Siegel on the potential ‘Superbug’ outbreak at UCLA hospital and why it is resistant.

  5. The big business of vaccines

    FBN’s Peter Barnes on the big, and growing, vaccine industry.

  6. Who will be the GOP nominee in 2016?

    GOP Fundraiser Michael Carrazza discusses the potential GOP candidates for the 2016 presidential election.

  7. Are cloud services like Box safe?

    Casaba Security Co-Founder Samuel Bucholtz on cloud computing, information safety and Box.

  8. Senator Warren says government gets credit for drug creation?

    Heritage Chief Economist Steve Moore discusses Sen. Elizabeth Warren’s, (D-Mass.), comments on medical innovations and tax dollars.

  9. Cubist Pharmaceuticals a long-term buy?

    FBN’s Charles Payne, NewOak Capital President James Frischling, small business expert Susan Solovic, retail analyst Hitha Prabhakar and Penn Financial Group founder Matt McCall on the outlook for Cubist Pharmaceuticals.

  10. Wadhwa on the future of innovation in health care

    Stanford University Fellow Vivek Wadhwa on how the tech industry will impact health care.

  11. Finding the right doctor and hospital for your needs Strategic Advisor Dr. Archelle Georgiou on helping consumers finding the right doctors and hospitals.

  12. Private hospital or government to blame for Ebola response?

    Black Rock Group Senior Director Lisa Boothe and Newsday columnist Ellis Henican on efforts to contain the Ebola crisis.

  1. $17B in deals hit Wall Street

    FBN’s Jo Ling Kent on UnitedHealth’s deal to buy Catamaran and the day’s other big M&A deals.

  2. What’s driving the markets?

    Nuveen Asset Management Chief Equity Strategist Bob Doll and Lane Generational CEO Fred Lane discuss deal flow and stock market performance.

  3. Should the strong dollar be feared?

    Shaffer Asset Management Dan Shaffer and FBN’s Neil Cavuto and Liz MacDonald on concerns about the impact of the strong dollar and General Motors’ legal troubles.

  4. 17-year old runs a hedge fund: What’s he investing in?

    Wohl Capital Investment Group founder Jacob Wohl joins the Making Money panel to discuss how he got his early start investing and the opportunities for investors in the biotech sector.

  5. Delivery by drone?

    FBN’s Rich Edson and Shira Ovide of The Wall Street Journal discuss how Amazon has been given approval by the FAA to test-fly drones.

  6. Heart disease risk cut in half with new drugs?

    Fox News Medical A-Team’s Dr. Marc Siegel discusses reports about new drugs that have the potential to reduce the risk of heart disease.

  7. How is the chicken industry changing?

    FBN’s Charles Payne, Penn Financial Group President Matt McCall, A&G Capital CIO & President Hilary Kramer, ‘Strange Inheritance’ Host Jamie Colby, Plimsoll Mark Managing Director Jim Awad and Capitalist Pig Founder Jonathan Hoenig on antibiotics and chickens.

‹ Prev12345Next ›
Freebase CC-BY
Source: Drug Companies on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL